9月18日 - ** 基因脚本生物科技公司（1548.HK）股价大涨8.2%，至40.28港元，创下自2021年12月以来的最高水平
** 受与礼来公司（Eli Lilly and Company）达成合作消息提振，该股延续前一交易日的涨势 LLY.N
** 该股成为恒生生物科技指数 .HSBIO 中涨幅第三大的个股，该指数当日上涨1.8%
** 周四，GenScript股价收高14.3%，创下自8月7日以来的最佳单日表现，此前该公司宣布 (link) 与礼来TuneLab（礼来旗下基于人工智能/机器学习的药物发现合作平台）展开合作
** GenScript将向TuneLab成员公司提供湿实验室服务，以生成实验数据，并将人工智能生成的预测转化为生物学证据
** 今年以来，该股累计上涨216.3%，恒生生物科技指数 .HSBIO 上涨11.2%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.